Clinical Proteomics
News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.
While technology advances were perhaps less dramatic than in the year prior, several firms teased future releases that could have significant impacts.
PrognomiQ Closes $34M Series D Round
The company said it will use the funding for development of its blood-based early detection test for lung cancer, which it plans to offer initially as an LDT and then as an IVD.
ADx NeuroSciences, Alamar Biosciences Form Biomarker Assay Alliance
The companies aim to work together to develop customized blood-based assays for clinical biomarker analysis.
ARPA-H Awards $110M to Commercial, Academic Teams Tackling Women's Health
The awardees included several diagnostics firms, among them Aspira Women's Health, which received $10 million for development of its EndoMDx test.
The company's technology allows researchers a largely automated option for measuring a large number of Alzheimer's and neurology biomarkers in blood.